Business / Finance RSS Feed - Business / Finance

Novel financing technique may unlock funding for developing 'orphan' drugs to treat rare diseases

Novel financing technique may unlock funding for developing 'orphan' drugs to treat rare diseases

A paper published today, "Financing translation: Analysis of the NCATS rare-diseases portfolio" in Science Translational Medicine, demonstrates the potential of a new financing technique to reduce the risk associated with investing in the treatment of new diseases and potentially unlock new levels of funding for developing so-called "orphan" drugs. [More]

Covalon reports financial results for first quarter 2014

Covalon Technologies Ltd., an advanced medical technologies company, today announced financial results for its first quarter ended December 31, 2014. [More]
Intrexon signs agreement to acquire Okanagan Specialty Fruits

Intrexon signs agreement to acquire Okanagan Specialty Fruits

Intrexon Corporation, a leader in synthetic biology, today announced it has entered into an agreement to acquire Okanagan Specialty Fruits, the pioneering agricultural company behind the Arctic apple, the world's first non-browning apple. [More]
Mylan acquires non-U.S. developed markets specialty and branded generics business from Abbott

Mylan acquires non-U.S. developed markets specialty and branded generics business from Abbott

Mylan N.V. and Mylan Inc. today announced the successful completion of the acquisition of Abbott Laboratories' non-U.S. developed markets specialty and branded generics business. [More]

TxCell invited to speak at largest US meeting for investors in emerging growth companies

In the presentation, Damian Marron will provide an overview of TxCell and its personalized T cell immunotherapy platform ASTrIA. Additional details will also be provided to institutional investors in one on one meetings at the conference. [More]

ChartSpan Medical Technologies raises $1.7 million in capital round

ChartSpan Medical Technologies announced it has successfully raised a capital round of $1.7 million dollars. Since becoming the most downloaded iPhone and iPad medical app in the U.S. in December, ChartSpan continues to disrupt healthcare with innovative technology empowering patients to manage their own healthcare records and information. [More]
ERT signs definitive agreement to acquire PHT

ERT signs definitive agreement to acquire PHT

ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, and PHT Corporation, the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research, announced today that they have signed a definitive agreement under which ERT will acquire PHT. [More]
Chiasma closes $70 million Series E financing round

Chiasma closes $70 million Series E financing round

Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round. [More]
Omnicell agrees to purchase MACH4 Pharma Systems

Omnicell agrees to purchase MACH4 Pharma Systems

Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems and pharmacies, today announced that it has signed an agreement to purchase MACH4 Pharma Systems, based in Bochum, Germany. [More]

Metrohm USA announces 2015 Young Chemist Award winner

Metrohm USA and Metrohm Canada are pleased to announce the winner of the 2015 Young Chemist Award, Chad Atkins. Chad is completing his Ph.D. at the University of British Columbia where he works under the supervision of Robin Turner and Michael Blades. [More]
Vectorious Medical Technologies closes $5 million financing round

Vectorious Medical Technologies closes $5 million financing round

Vectorious Medical Technologies, an Israeli company developing a novel cardiac monitoring system for patients suffering from congestive heart failure (CHF), announced today that it has closed a $5 million financing round. [More]

Lyric announces initial closing of $20.4 million Series A financing round

Lyric Pharmaceuticals Inc. today announced the initial closing of a Series A financing round totaling $20.4 million. The financing, co-led by RiverVest Venture Partners, Sante Ventures and Third Point Ventures, includes participation by Aperture Venture Partners. [More]
HeartWare International's revenue increases 38% to $73.2 million in Q4 2014

HeartWare International's revenue increases 38% to $73.2 million in Q4 2014

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013. [More]
Cipher acquires worldwide rights to three products from Astion

Cipher acquires worldwide rights to three products from Astion

Cipher Pharmaceuticals Inc. today announced it has strengthened its product pipeline by acquiring the worldwide rights to three products from Astion Pharma, a Denmark-based specialty pharmaceutical company. [More]
MiMedx Group reports record revenue of $118.2 million for full year 2014

MiMedx Group reports record revenue of $118.2 million for full year 2014

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the fourth quarter and full year ended December 31, 2014. [More]

Bruker-sponsored sixth AFM Biomed conference highlights increasing impact of AFM in biological applications

Bruker recently sponsored the sixth AFM BioMed International Meeting on AFM in Life Sciences and NanoMedicine. Held last month at the Sanford Consortium for Regenerative Medicine in La Jolla, CA, the conference brought together more than 125 scientists from around the world. [More]

Shortlist announced for world leading healthcare awards

Companies from across the UK have been announced as part of the shortlist for the prestigious Medilink UK Awards 2015 - celebrating cutting edge technologies, outstanding business achievements and international success across the UK’s Life Sciences sector. [More]
Prexton closes €8.7 million in Series A financing to develop treatments for Parkinson’s disease

Prexton closes €8.7 million in Series A financing to develop treatments for Parkinson’s disease

Prexton Therapeutics, a biopharmaceutical company developing novel therapeutic compounds for the treatment of CNS conditions including Parkinson’s disease, today announces the closing of a Series A financing of €8.7 million ($10 million) co-led by Sunstone Capital and Ysios Capital. [More]
Sotera Wireless announces acquisition of Reflectance Medical

Sotera Wireless announces acquisition of Reflectance Medical

Sotera Wireless, Inc. today announced its acquisition of Reflectance Medical Inc., a privately held company that has developed first-of-its kind technology aimed at detecting potentially life threatening conditions in critically ill patients, including those who have suffered trauma injuries. [More]

Berthold Technologies introduces Biametrics GmbH as a new co-operation partner

Berthold Technologies proudly announces the recently established co-operation with their new partner Biametrics GmbH. [More]